Vanda Pharmaceuticals Set to Announce Financial Results
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) has announced that it will release its financial results for the first quarter of 2025 shortly after the market closes on Wednesday, May 7, 2025. This pivotal moment will allow the company to showcase its performance and strategic directions.
Conference Call and Webcast Details
The financial results will be followed by a conference call at 4:30 PM ET on the same day. During this call, the management team at Vanda will discuss the financial results alongside other significant corporate activities intended to inform investors and stakeholders.
How to Participate
Those interested in participating in the call can join by dialing 1-800-715-9871 for domestic calls or 1-646-307-1963 for international calls using the passcode 9941754. It is highly encouraged that callers dial in a few minutes early to ensure a smooth connection.
Accessing the Webcast
In addition to the live call, Vanda’s conference will be broadcast simultaneously via a webcast, which will also be archived on their official website. Investors should plan on visiting Vanda's site at least 15 minutes early to register and download any necessary audio software for the event.
Replay Information for the Call
A replay of the conference call will also be offered starting from 8:30 PM ET on May 7, 2025. This will allow those who cannot attend the live call to access the information discussed. The replay will be available until 11:59 PM ET on Wednesday, May 14, 2025. To access the replay, callers can use the same domestic call-in number, 1-800-770-2030, or 1-609-800-9909 for international callers, with the same passcode of 9941754.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals is a prominent biopharmaceutical company dedicated to developing and marketing innovative therapies that meet significant medical needs for various conditions. Their commitment to improving patient care drives their continuous research and development efforts.
Latest Developments
Recently, Vanda has focused on expanding its portfolio of treatments, emphasizing their dedication to addressing high unmet medical needs. With advancements in clinical trials and partnerships with other organizations, they are striving to bring effective solutions to patients around the world.
Corporate Communications
For any inquiries, Kevin Moran, the Senior Vice President and Chief Financial Officer, is the primary contact. Vanda continues to communicate transparently with stakeholders through various channels, sharing updates and engaging with the community.
Frequently Asked Questions
What is the date of Vanda Pharmaceuticals' Q1 2025 results announcement?
The announcement is set for May 7, 2025, after the market closes.
How can I join the conference call?
You can join by dialing 1-800-715-9871 for domestic calls or 1-646-307-1963 for international calls, using passcode 9941754.
Is there a way to access the replay of the conference call?
Yes, the replay will be available starting at 8:30 PM ET on May 7, 2025, until 11:59 PM ET on May 14, 2025.
Where can I find more information about Vanda Pharmaceuticals?
Detailed information can be found on Vanda's official website, which offers insights into their products, services, and mission.
Who can I contact for more inquiries about Vanda Pharmaceuticals?
Kevin Moran, the Senior Vice President and CFO, can be contacted for further inquiries regarding the company.